Friday, 24 March 2017 17:22
Cuban Vaccine against Lung Cancer Goes to Clinical Trial at Primary Health Care Level
Havana, Cuba.- With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world.
Published in
Health
